OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project
Shikha Singla, André Lucas Ribeiro, Murat Torğutalp, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003809-e003809
Open Access | Times Cited: 18

Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis
Lihi Eder, Sivakami Mylvaganam, Jordi Pardo Pardo, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 12, pp. e716-e727
Closed Access | Times Cited: 15

Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists
Álvaro González‐Cantero, M. Constantin, Annunziata Dattola, et al.
International Journal of Women’s Dermatology (2023) Vol. 9, Iss. 4, pp. e112-e112
Open Access | Times Cited: 13

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
Lars Erik Kristensen, Atul Deodhar, Ying Ying Leung, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 3, pp. 487-499
Open Access | Times Cited: 4

Sex Differences in the Effectiveness of First‐Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
Pasoon Hellamand, M. G. H. Van de Sande, Lykke Midtbøll Ørnbjerg, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 4, pp. 587-598
Open Access | Times Cited: 5

Managing psoriatic arthritis in different clinical scenarios
Rubén Queiró, Marta Loredo, Ignacio Braña, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1469-1484
Closed Access | Times Cited: 4

Adalimumab/tofacitinib

Reactions Weekly (2024) Vol. 2002, Iss. 1, pp. 23-23
Closed Access

Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey
Lihi Eder, Pascal Richette, Laura C. Coates, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 5, pp. 1115-1134
Open Access

Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies
Fadi Kharouf, Dafna D. Gladman
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 11, pp. 1381-1400
Closed Access

The Persistence of Biologic Therapies for Psoriatic Arthritis
Magdalena Jasmen, Dominga García, Sebastián Ibañez, et al.
JCR Journal of Clinical Rheumatology (2024)
Closed Access

Efficacy of tofacitinib in psoriatic arthritis: literature review and case report
Г. И. Гриднева, E. S. Aronova
Meditsinskiy sovet = Medical Council (2023), Iss. 21, pp. 143-150
Open Access

Page 1

Scroll to top